カワチ薬品 announced its second-quarter results for the fiscal year ending March 2027. Consolidated net income decreased 8.6% year on year. Revenue was ¥144.143 billion.
カワチ薬品 announced its second-quarter results for the fiscal year ending March 2027. The results were disclosed on a consolidated basis after the market close on 28 October.
Revenue for the reported period was ¥144.143 billion. Net income decreased 8.6% year on year.